US20020081327A1 - Direct pour-on antiparasitic skin solution and methods for treating, preventing and controlling myasis - Google Patents
Direct pour-on antiparasitic skin solution and methods for treating, preventing and controlling myasis Download PDFInfo
- Publication number
- US20020081327A1 US20020081327A1 US09/450,186 US45018699A US2002081327A1 US 20020081327 A1 US20020081327 A1 US 20020081327A1 US 45018699 A US45018699 A US 45018699A US 2002081327 A1 US2002081327 A1 US 2002081327A1
- Authority
- US
- United States
- Prior art keywords
- compound
- alkyl
- haloalkyl
- formula
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 [1*]C1=NN(C2=*C=C([13*])C=C2[11*])C([4*])=C1[2*] Chemical compound [1*]C1=NN(C2=*C=C([13*])C=C2[11*])C([4*])=C1[2*] 0.000 description 4
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/48—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
- A01N43/56—1,2-Diazoles; Hydrogenated 1,2-diazoles
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
- A01N47/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having no bond to a nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
Definitions
- the present invention relates to a direct pour-on skin solution which contains an antiparasitic product and is intended to be applied topically to cattle and sheep.
- the invention also relates to the use of antiparasitic compounds for the preparation of this skin solution, as well as to a treatment process relating thereto.
- the main ones are ticks of the genus Boophilus, among which mention may be made of the species microplus (cattle tick), decoloratus and anulatus.
- myiases such as Dermatobia hominis (known as Berne in Brazil) and Cochlyomia hominivorax (greenbottle); sheep myiases such as Lucilia sericata, Lucilia cuprina (known as blowfly strike in Australia, New Zealand and South Africa). These are flies whose larva constitutes the animal parasite.
- flies proper namely those whose adult constitutes the parasite, such as Haematobia irritans (horn fly).
- galls such as Sarcoptes scabiei and Psoroptes ovis.
- Ticks in particular Boophilus microplus, are very closely attached to the pasture in which they live and are particularly difficult to control.
- WO-A-87/3781, EP-A-295,117 and EP-A-500,209 describe a class of insecticides which are N-phenyl-pyrazole derivatives. These compounds are given as having activity against a very large number of parasites, including Boophilus microplus, in fields as varied as agriculture, public health and veterinary medicine.
- the general teaching of these documents indicates that these insecticidal compounds may be administered via different routes; oral, parenteral, percutaneous and topical routes.
- Topical administration comprises, in particular, oral formulations, baits, dietary supplements, skin solutions (pour-on), solutions for spraying (sprays), baths, showers, jets, powders, greases, shampoos, creams, etc.
- Example 9 of EP-A-295,117 and Example 29I of EP-A-500,209 describe a pour-on type skin solution containing 15% insecticide and 85% dimethyl sulphoxide, for percutaneous administration of the insecticide.
- EP-A-296,381 also describes pyrazole compounds having insecticidal activity in the field of agriculture, public health and veterinary medicine. Boophilus microplus is one of the very many targets mentioned. There are very many forms of administration here also, and these include, for example, solutions, emulsions, suspensions, powders, pastes, granules and aerosols.
- the problem which is posed is to find an effective means which is entirely suitable for controlling the parasites of cattle and sheep, in particular ticks, most particularly Boophilus microplus in cattle and in particular lice and blowfly in sheep, under the conditions in which these animals are reared.
- Boophilus microplus for cattle using a specific topical formulation.
- This formulation is effective against sheep lice and sheep flies known as “blowfly”.
- the aim of the present invention is thus to provide a novel composition which is entirely effective against Boophilus microplus and also against all of the other parasites described above such as, in particular, sheep lice and “blowfly”, this composition being entirely suitable for controlling these parasites under the conditions in which these animals are reared.
- Another aim of the invention is to provide such a formulation which has a long period of efficacy, preferably longer than or equal to two months.
- Another aim of the invention is to provide such a formulation which is quick and easy to use and entirely compatible with use on herds or flocks containing a large number of animals.
- Another aim of the invention is to provide such a formulation which is particularly suitable for extensive pasture rearing and for use intended to protect animals during the period of rounding up and finishing (Feed Lot in USA), namely the final period of rearing in which a large number of animals are herded into a small enclosure over an average period of two months preceding slaughter.
- the subject of the present invention is thus a direct pour-on skin solution, intended to eliminate parasites from cattle and sheep, most particularly ticks, especially Boophilus microplus in cattle and lice and blowfly in sheep, comprising from 0.05 to 25% weight/volume, relative to the total solution, of a compound of formula (I)
- R 1 is CN or methyl or a halogen atom
- R 2 is S(O) n R 3 or 4,5-dicyanoimidazol-2-yl or haloalkyl;
- R 3 is alkyl or haloalkyl
- R 4 represents a hydrogen or halogen atom; or a radical NR 5 R 6 , S(O) m R 7 , C(O)R 7 , C(O)O—R 7 , alkyl, haloalkyl or OR 8 or a radical —N ⁇ C(R 9 )(R 10 ) ;
- R 5 and R 6 independently represent a hydrogen atom or an alkyl, haloalkyl, C(O)alkyl, alkoxycarbonyl or S(O) r CF 3 radical; or R 5 and R 6 may together form a divalent alkylene radical which may be interrupted by one or two divalent hetero atoms, such as oxygen or sulphur;
- R 7 represents an alkyl or haloalkyl radical
- R 8 represents an alkyl or haloalkyl radical or a hydrogen atom
- R 9 represents an alkyl radical or a hydrogen atom
- R 10 represents a phenyl or heteroaryl group optionally substituted with one or more halogen atoms or groups such as OH, —O-alkyl, —S-alkyl, cyano or alkyl;
- R 11 and R 12 represent, independently of each other, a hydrogen or halogen atom, or optionally CN or NO 2 ;
- R 13 represents a halogen atom or a haloalkyl, haloalkoxy, S(O) q CF 3 or SF 5 group;
- m, n, q, and r represent, independently of each other, an integer equal to 0, 1 or 2;
- X represents a trivalent nitrogen atom or a radical C—R 12 , the other three valency positions of the carbon atom forming part of the aromatic ring;
- R 1 when R 1 is methyl, either R 3 is haloalkyl, R 4 is NH 2 , R 11 is Cl, R 13 is CF 3 and X is N; or R 2 is 4,5-dicyanoimidazol-2-yl, R 4 is Cl, R 11 is Cl, R 13 is CF 3 and X is ⁇ C—C1;
- R 1 is CN or methyl
- R 2 is S(O) n R 3 ;
- R 3 is alkyl or haloalkyl
- R 4 represents a hydrogen or halogen atom; or a radical NR 5 R 6 , S(O) m R 7 , C(O)R 7 , alkyl, haloalkyl or OR 8 or a radical —N ⁇ C(R 9 )(R 10 );
- R 5 and R 6 independently represent a hydrogen atom or an alkyl, haloalkyl, C(O)alkyl or S(O) r CF 3 radical; or R 5 and R 6 may together form a divalent alkylene radical which may be interrupted by one or two divalent hetero atoms, such as oxygen or sulphur;
- R 7 represents an alkyl or haloalkyl radical
- R 8 represents an alkyl or haloalkyl radical or a hydrogen atom
- R 9 represents an alkyl radical or a hydrogen atom
- R 10 represents a phenyl or heteroaryl group optionally substituted with one or more halogen atoms or groups such as OH, —O-alkyl, —S-alkyl, cyano or alkyl;
- R 11 and R 12 represent, independently of each other, a hydrogen or halogen atom
- R 13 represents a halogen atom or a haloalkyl, haloalkoxy, S(O) q CF 3 or SF 5 group;
- m, n, q, and r represent, independently of each other, an integer equal to 0, 1 or 2;
- X represents a trivalent nitrogen atom or a radical C—R 12 , the other three valency positions of the carbon atom forming part of the aromatic ring;
- R 1 when R 1 is methyl, then R 3 is haloalkyl, R 4 is NH 2 , R 11 is Cl, R 13 is CF 3 and X is N.
- concentrations of from 0.05 to 10% weight/volume, more particularly from 0.1 to 2%, are preferred. Optimally, the value is between 0.25 and 1.5%, in particular in the region of 1%.
- the expression pour-on skin solution is understood to refer to a ready-to-use solution intended to be applied topically and locally on the animal, preferably on the animal's back and at several points or along the line of the back, and applied in low volume, preferably of 5 to 20 ml per 100 kg, preferably about 10 ml per 100 kg, with a total volume of from 10 to 150 ml per animal, preferably limited to 50 ml.
- the compound acts by simple contact, the parasite becoming impregnated with the compound on contact with the hairs and the skin.
- the solution according to the present invention is applied topically, in low volume, to the animal's back.
- the compound of formula (I) then diffuses out in a noteworthy manner, this being reflected by a distribution of the compound over the animal's entire body. It has also been observed that the animals remained protected in the case of passage through water or exposure to rain.
- the dose of compound of formula (I) is preferably between 0.1 and 2 mg/kg (animal weight), preferably between 0.25 and 1.5 mg/kg, and in particular about 1 mg/kg.
- R 1 is CN
- R 11 is a halogen atom and those in which R 13 is haloalkyl, preferably CF 3
- compounds combining two or more of these characteristics will advantageously be selected.
- a preferred class of compounds of formula (I) consists of compounds such that R 1 is CN, R 3 is haloalkyl, preferably CF 3 , or ethyl, R 4 is NH 2 , R 11 and R 12 are, independently of each other, a halogen atom, and/or R 13 is haloalkyl.
- the alkyl radicals may contain generally from 1 to 6 carbon atoms.
- the cycle formed between the divalent alkylene radical representing R 5 and R 6 , as well as with the nitrogen atom to which R 5 and R 6 are attached, may be generally a cycle of 5, 6 or 7 links.
- a most particularly preferred compound of the formula (I) in the invention is 1-[2,6-Cl 2 4-CF 3 phenyl]3-CN 4-[SO—CF 3 ]5-NH 2 pyrazole, referred to hereinbelow as compound A.
- This compound A will be used in particular in a proportion of from 0.1 to 2% by weight, more particularly about 1%, relative to the total solution.
- R 3 ethyl
- the compounds of formula (I) may be prepared according to one or other of the processes described in patent applications WO-A-87/3781, 93/6089, 94/21606 or European patent application EP-A-0,295,117, or any other process which falls within the competence of a specialist skilled in the art of chemical synthesis.
- a person skilled in the art is considered as having at his or her disposal, inter alia, all the contents of “Chemical Abstracts” and the documents cited therein.
- solutions according to the invention which are advantageously oily, generally comprise a diluent or vehicle and also a solvent (organic solvent) for the compound of formula (I) if the latter is not soluble in the diluent.
- organic solvent which can be used in the invention, mention may be made in particular of: acetyltributyl citrate, fatty acid esters such as the dimethyl ester, diisobutyl adipate, acetone, acetonitrile, benzyl alcohol, butyl diglycol, dimethylacetamide, dimethylformamide, dipropylene glycol n-butyl ether, ethanol, isopropanol, methanol, ethylene glycol monoethyl ether, ethylene glycol monomethyl ether, monomethylacetamide, dipropylene glycol monomethyl ether, liquid polyoxyethylene glycols, propylene glycol, 2-pyrrolidone, in particular N-methylpyrrolidone, diethylene glycol monoethyl ether, ethylene glycol and diethyl phthalate, or a mixture of at least two of these solvents.
- acetyltributyl citrate fatty acid esters such as the dimethyl ester, diis
- plant oils such as soybean oil, groundnut oil, castor oil, corn oil, cotton oil, olive oil, grape seed oil, sunflower oil, etc.; mineral oils such as petrolatum, paraffin, silicone, etc.; aliphatic or cyclic hydrocarbons or alternatively, for example, medium-chain (C8 to C12 in particular) triglycerides.
- An emollient and/or spreading and/or film-forming agent will preferably be added, this agent being selected in particular from:
- polyvinylpyrrolidone polyvinyl alcohols, copolymers of vinyl acetate and vinylpyrrolidone, polyethylene glycols, benzyl alcohol, mannitol, glycerol, sorbitol, polyoxyethylenated sorbitan esters; lecithin, sodium carboxymethylcellulose, silicone oils, polydiorganosiloxane oils, in particular polydimethylsiloxane (PDMS) oils, for example those containing silanol functionalities, or a 45V2 oil,
- PDMS polydimethylsiloxane
- anionic surfactants such as alkaline stearates, in particular sodium, potassium or ammonium stearates; calcium stearate, triethanolamine stearate; sodium abietate; alkyl sulphates, in particular sodium lauryl sulphate and sodium cetyl sulphate; sodium dodecylbenzenesulphonate, sodium dioctylsulphosuccinate; fatty acids, in particular those derived from coconut oil,
- cationic surfactants such as water-soluble quaternary ammonium salts of formula N + R′R′′R′′′R′′′′, Y ⁇ in which the radicals R are optionally hydroxylated hydrocarbon radicals and Y ⁇ is an anion of a strong acid such as the halide, sulphate and sulphonate anions; cetyltrimethylammonium bromide is among the cationic surfactants which can be used,
- nonionic surfactants such as sorbitan esters, which are optionally polyoxyethylenated, in particular polysorbate 80, polyoxyethylenated alkyl ethers; polyoxypropylated fatty alcohols such as polyoxypropylene-styrol ether; polyethylene glycol stearate, polyoxyethylenated derivatives of castor oil, polyglycerol esters, polyoxyethylenated fatty alcohols, polyoxyethylenated fatty acids, copolymers of ethylene oxide and propylene oxide,
- sorbitan esters which are optionally polyoxyethylenated, in particular polysorbate 80, polyoxyethylenated alkyl ethers; polyoxypropylated fatty alcohols such as polyoxypropylene-styrol ether; polyethylene glycol stearate, polyoxyethylenated derivatives of castor oil, polyglycerol esters, polyoxyethylenated
- amphoteric surfactants such as the substituted lauryl compounds of betaine
- the solvent will be used in proportion with the concentration of the compound I and its solubility in this solvent.
- compound A has a solubility of 4.3% m/V in acetyl tributyl citrate. It will be sought to have the lowest possible volume.
- the emollient is preferably used in a proportion of from 0.1 to 10%, in particular from 0.25 to 5%, by volume.
- the subject of the present invention is also a process for the elimination of parasites, in particular Boophilus microplus , from cattle and sheep using a direct pour-on skin solution according to the present invention, so as obtain long-lasting and broad-spectrum efficacy, the solution being applied to the animal's back, preferably along the line of the back at one or more points.
- the process consists in applying the solution to the animals in pasture and/or before they arrive in pasture, the application preferably being repeated every month, preferably every two months.
- the process consists in applying the solution to the animals before they arrive in the “feed Lot”, it being possible for this application to be the final one before the animals are slaughtered.
- the process may also consist in combining these two embodiments, namely the first followed by the second.
- the efficacy advantageously makes it possible to stop any application 1 to 3 months before slaughter, in particular between 1.5 and 2.5 months, more particularly about two months before slaughter.
- solutions according to the invention may be applied using any means known per se, preferably using an applicator gun or a metering flask.
- the aim of the method is not therapeutic and is, in particular, to cleanse the skin and the hairs of the animals by eliminating the parasites which are present thereon, as well as their residues and dejections.
- the result of this is that the animals are no longer stressed by the parasites and their bites, this having positive consequences, for example on their growth and on the use of their food ration.
- Another subject of the invention is a therapeutic method using the external device according to the invention, intended for the treatment and prevention of parasitoses having pathogenic consequences.
- the subject of the present invention is also the use of the compounds I, in particular compound A, for the manufacture of a direct pour-on skin solution comprising the compound (I) in a low volume and designed to release the compound (I) onto the skin and the hairs for a contact action against the parasites of cattle and sheep, in particular cattle ticks, such as Boophilus microplus, and sheep blowfly and lice.
- the use according to the invention is directed towards producing skin solutions as described above.
- FIG. 1 is a graph showing the efficacy, against Boophilus microplus , of skin solutions according to the invention, with a 0.25%, 0.5% and 1% content, relative to a control, this graph including, on the x-axis, the time in days after application of the skin solutions, and, on the y-axis to the left, the number of ticks counted on the animals on which the skin solutions according to the invention are applied, and, on the y-axis to the right, the number of ticks counted in the controls;
- FIG. 2 is a graph showing the population of ticks in animals which have received the placebo according to Example 2, with, on the x-axis, the time in days, and, on the y-axis, the number of ticks;
- FIG. 3 compares the efficacy of a skin solution according to the invention containing 1% compound A (solid circles) with a skin solution containing 1% flumethrin (rings), with, on the x-axis, the time in days, and, on the y-axis, the number of ticks.
- Compound A is dissolved in the solvent before being mixed with the other ingredients.
- a placebo was prepared, which differed from the skin solutions according to the invention in that it contained no compound A.
- the dose volume was applied along the line of the animal's back, from the head to the base of the tail.
- Table 2 indicates, for each group, the weight of the animals, the dose of skin solution received and the dose of active substance applied.
- FIGS. 2 and 3 demonstrate the total efficacy of the skin solution according to the invention.
- composition of these solutions is the same as for the above examples.
- the cattle were preinfested so as to have all of the stages of Boophilus microplus present (infestation with 5,000 larvae, 22 days, 15 days and 8 days before application of the skin solution).
Abstract
Description
- The present invention relates to a direct pour-on skin solution which contains an antiparasitic product and is intended to be applied topically to cattle and sheep.
- The invention also relates to the use of antiparasitic compounds for the preparation of this skin solution, as well as to a treatment process relating thereto.
- Cattle and sheep are affected by a large number of parasites.
- The main ones are ticks of the genus Boophilus, among which mention may be made of the speciesmicroplus (cattle tick), decoloratus and anulatus.
- The other main parasites of cattle and sheep are indicated in order of decreasing importance:
- myiases such asDermatobia hominis (known as Berne in Brazil) and Cochlyomia hominivorax (greenbottle); sheep myiases such as Lucilia sericata, Lucilia cuprina (known as blowfly strike in Australia, New Zealand and South Africa). These are flies whose larva constitutes the animal parasite.
- flies proper, namely those whose adult constitutes the parasite, such asHaematobia irritans (horn fly).
- lice such asLinognathus vitulorum, etc.
- galls such asSarcoptes scabiei and Psoroptes ovis.
- Ticks, in particularBoophilus microplus, are very closely attached to the pasture in which they live and are particularly difficult to control.
- There is at the present time no truly effective method for controlling ticks, and less still an effective way of controlling the set of parasites indicated above.
- WO-A-87/3781, EP-A-295,117 and EP-A-500,209 describe a class of insecticides which are N-phenyl-pyrazole derivatives. These compounds are given as having activity against a very large number of parasites, includingBoophilus microplus, in fields as varied as agriculture, public health and veterinary medicine. The general teaching of these documents indicates that these insecticidal compounds may be administered via different routes; oral, parenteral, percutaneous and topical routes. Topical administration comprises, in particular, oral formulations, baits, dietary supplements, skin solutions (pour-on), solutions for spraying (sprays), baths, showers, jets, powders, greases, shampoos, creams, etc. The pour-on type skin solutions are designed for percutaneous administration. Example 9 of EP-A-295,117 and Example 29I of EP-A-500,209 describe a pour-on type skin solution containing 15% insecticide and 85% dimethyl sulphoxide, for percutaneous administration of the insecticide.
- EP-A-296,381 also describes pyrazole compounds having insecticidal activity in the field of agriculture, public health and veterinary medicine.Boophilus microplus is one of the very many targets mentioned. There are very many forms of administration here also, and these include, for example, solutions, emulsions, suspensions, powders, pastes, granules and aerosols.
- The problem which is posed is to find an effective means which is entirely suitable for controlling the parasites of cattle and sheep, in particular ticks, most particularlyBoophilus microplus in cattle and in particular lice and blowfly in sheep, under the conditions in which these animals are reared.
- The Applicant has found that it is possible to effectively controlBoophilus microplus for cattle using a specific topical formulation. The Applicant has also found that this formulation is effective against sheep lice and sheep flies known as “blowfly”.
- The aim of the present invention is thus to provide a novel composition which is entirely effective againstBoophilus microplus and also against all of the other parasites described above such as, in particular, sheep lice and “blowfly”, this composition being entirely suitable for controlling these parasites under the conditions in which these animals are reared.
- Another aim of the invention is to provide such a formulation which has a long period of efficacy, preferably longer than or equal to two months.
- Another aim of the invention is to provide such a formulation which is quick and easy to use and entirely compatible with use on herds or flocks containing a large number of animals.
- Another aim of the invention is to provide such a formulation which is particularly suitable for extensive pasture rearing and for use intended to protect animals during the period of rounding up and finishing (Feed Lot in USA), namely the final period of rearing in which a large number of animals are herded into a small enclosure over an average period of two months preceding slaughter.
-
- in which:
- R1 is CN or methyl or a halogen atom;
- R2 is S(O)nR3 or 4,5-dicyanoimidazol-2-yl or haloalkyl;
- R3 is alkyl or haloalkyl;
- R4 represents a hydrogen or halogen atom; or a radical NR5R6, S(O)mR7, C(O)R7, C(O)O—R7, alkyl, haloalkyl or OR8 or a radical —N═C(R9)(R10) ;
- R5 and R6 independently represent a hydrogen atom or an alkyl, haloalkyl, C(O)alkyl, alkoxycarbonyl or S(O)rCF3 radical; or R5 and R6 may together form a divalent alkylene radical which may be interrupted by one or two divalent hetero atoms, such as oxygen or sulphur;
- R7 represents an alkyl or haloalkyl radical;
- R8 represents an alkyl or haloalkyl radical or a hydrogen atom;
- R9 represents an alkyl radical or a hydrogen atom;
- R10 represents a phenyl or heteroaryl group optionally substituted with one or more halogen atoms or groups such as OH, —O-alkyl, —S-alkyl, cyano or alkyl;
- R11 and R12 represent, independently of each other, a hydrogen or halogen atom, or optionally CN or NO2;
- R13 represents a halogen atom or a haloalkyl, haloalkoxy, S(O)qCF3 or SF5 group;
- m, n, q, and r represent, independently of each other, an integer equal to 0, 1 or 2;
- X represents a trivalent nitrogen atom or a radical C—R12, the other three valency positions of the carbon atom forming part of the aromatic ring;
- with the proviso that, when R1 is methyl, either R3 is haloalkyl, R4 is NH2, R11 is Cl, R13 is CF3 and X is N; or R2 is 4,5-dicyanoimidazol-2-yl, R4 is Cl, R11 is Cl, R13 is CF3 and X is ═C—C1;
- in a formulation at low volume, designed to release the compound (I) onto the skin and the hairs for a contact action against parasites.
- Preferably, in formula (I),
- R1 is CN or methyl;
- R2 is S(O)nR3;
- R3 is alkyl or haloalkyl;
- R4 represents a hydrogen or halogen atom; or a radical NR5R6, S(O)mR7, C(O)R7, alkyl, haloalkyl or OR8 or a radical —N═C(R9)(R10);
- R5 and R6 independently represent a hydrogen atom or an alkyl, haloalkyl, C(O)alkyl or S(O)rCF3 radical; or R5 and R6 may together form a divalent alkylene radical which may be interrupted by one or two divalent hetero atoms, such as oxygen or sulphur;
- R7 represents an alkyl or haloalkyl radical;
- R8 represents an alkyl or haloalkyl radical or a hydrogen atom;
- R9 represents an alkyl radical or a hydrogen atom;
- R10 represents a phenyl or heteroaryl group optionally substituted with one or more halogen atoms or groups such as OH, —O-alkyl, —S-alkyl, cyano or alkyl;
- R11 and R12 represent, independently of each other, a hydrogen or halogen atom;
- R13 represents a halogen atom or a haloalkyl, haloalkoxy, S(O)qCF3 or SF5 group;
- m, n, q, and r represent, independently of each other, an integer equal to 0, 1 or 2;
- X represents a trivalent nitrogen atom or a radical C—R12, the other three valency positions of the carbon atom forming part of the aromatic ring;
- with the proviso that, when R1 is methyl, then R3 is haloalkyl, R4 is NH2, R11 is Cl, R13 is CF3 and X is N.
- However, low concentrations of from 0.05 to 10% weight/volume, more particularly from 0.1 to 2%, are preferred. Optimally, the value is between 0.25 and 1.5%, in particular in the region of 1%.
- The expression pour-on skin solution is understood to refer to a ready-to-use solution intended to be applied topically and locally on the animal, preferably on the animal's back and at several points or along the line of the back, and applied in low volume, preferably of 5 to 20 ml per 100 kg, preferably about 10 ml per 100 kg, with a total volume of from 10 to 150 ml per animal, preferably limited to 50 ml.
- The compound acts by simple contact, the parasite becoming impregnated with the compound on contact with the hairs and the skin.
- This thereby affords, in a noteworthy manner, a both perfect compatibility with the restrictions of use in extensive grazing, in terms of ease of use in particular, and a spectrum of activity and of efficacy, as well as a period of efficacy, which are suited to this type of rearing.
- By working on the concentration of compound (I), in particular of compound A, solutions having noteworthy activities are obtained with, in particular, two months of efficacy againstBoophilus microplus, this result never before having been achieved. Moreover, the solution according to the invention allows Boophilus microplus to be totally eliminated from an infested animal in less than 2 days.
- As has been stated above, the solution according to the present invention is applied topically, in low volume, to the animal's back. The compound of formula (I) then diffuses out in a noteworthy manner, this being reflected by a distribution of the compound over the animal's entire body. It has also been observed that the animals remained protected in the case of passage through water or exposure to rain.
- The dose of compound of formula (I) is preferably between 0.1 and 2 mg/kg (animal weight), preferably between 0.25 and 1.5 mg/kg, and in particular about 1 mg/kg.
- The compounds of formula (I) in which R1 is CN will be selected most particularly. The compounds in which R2 is S(O)nR3, preferably with n=1, R3 preferably being CF3 or alkyl, for example methyl or ethyl, or alternatively n=0, R3 preferably being CF3, as well as those in which X=C—R12, R12 being a halogen atom, will also be selected. The compounds in which R11 is a halogen atom and those in which R13 is haloalkyl, preferably CF3, are also preferred. In the context of the present invention, compounds combining two or more of these characteristics will advantageously be selected.
- A preferred class of compounds of formula (I) consists of compounds such that R1 is CN, R3 is haloalkyl, preferably CF3, or ethyl, R4 is NH2, R11 and R12 are, independently of each other, a halogen atom, and/or R13 is haloalkyl.
- In the present invention, the alkyl radicals may contain generally from 1 to 6 carbon atoms. The cycle formed between the divalent alkylene radical representing R5 and R6, as well as with the nitrogen atom to which R5 and R6 are attached, may be generally a cycle of 5, 6 or 7 links.
- A most particularly preferred compound of the formula (I) in the invention is 1-[2,6-Cl2 4-CF3phenyl]3-CN 4-[SO—CF3]5-NH2pyrazole, referred to hereinbelow as compound A. This compound A will be used in particular in a proportion of from 0.1 to 2% by weight, more particularly about 1%, relative to the total solution.
- Mention may also be made of the two compounds which differ from the above by the following characteristics:
- 1−n=0,
- 2−n=1,
- R3=CF3
- R3=ethyl.
- The compounds of formula (I) may be prepared according to one or other of the processes described in patent applications WO-A-87/3781, 93/6089, 94/21606 or European patent application EP-A-0,295,117, or any other process which falls within the competence of a specialist skilled in the art of chemical synthesis. For the chemical preparation of the products of the invention, a person skilled in the art is considered as having at his or her disposal, inter alia, all the contents of “Chemical Abstracts” and the documents cited therein.
- It is not departing from the scope of the present invention to incorporate other insecticides into the solution according to the present invention.
- The solutions according to the invention, which are advantageously oily, generally comprise a diluent or vehicle and also a solvent (organic solvent) for the compound of formula (I) if the latter is not soluble in the diluent.
- As organic solvent which can be used in the invention, mention may be made in particular of: acetyltributyl citrate, fatty acid esters such as the dimethyl ester, diisobutyl adipate, acetone, acetonitrile, benzyl alcohol, butyl diglycol, dimethylacetamide, dimethylformamide, dipropylene glycol n-butyl ether, ethanol, isopropanol, methanol, ethylene glycol monoethyl ether, ethylene glycol monomethyl ether, monomethylacetamide, dipropylene glycol monomethyl ether, liquid polyoxyethylene glycols, propylene glycol, 2-pyrrolidone, in particular N-methylpyrrolidone, diethylene glycol monoethyl ether, ethylene glycol and diethyl phthalate, or a mixture of at least two of these solvents.
- As vehicle or diluent, mention may be made in particular of:
- plant oils such as soybean oil, groundnut oil, castor oil, corn oil, cotton oil, olive oil, grape seed oil, sunflower oil, etc.; mineral oils such as petrolatum, paraffin, silicone, etc.; aliphatic or cyclic hydrocarbons or alternatively, for example, medium-chain (C8 to C12 in particular) triglycerides.
- An emollient and/or spreading and/or film-forming agent will preferably be added, this agent being selected in particular from:
- polyvinylpyrrolidone, polyvinyl alcohols, copolymers of vinyl acetate and vinylpyrrolidone, polyethylene glycols, benzyl alcohol, mannitol, glycerol, sorbitol, polyoxyethylenated sorbitan esters; lecithin, sodium carboxymethylcellulose, silicone oils, polydiorganosiloxane oils, in particular polydimethylsiloxane (PDMS) oils, for example those containing silanol functionalities, or a 45V2 oil,
- anionic surfactants such as alkaline stearates, in particular sodium, potassium or ammonium stearates; calcium stearate, triethanolamine stearate; sodium abietate; alkyl sulphates, in particular sodium lauryl sulphate and sodium cetyl sulphate; sodium dodecylbenzenesulphonate, sodium dioctylsulphosuccinate; fatty acids, in particular those derived from coconut oil,
- cationic surfactants such as water-soluble quaternary ammonium salts of formula N+R′R″R″′R″″, Y− in which the radicals R are optionally hydroxylated hydrocarbon radicals and Y− is an anion of a strong acid such as the halide, sulphate and sulphonate anions; cetyltrimethylammonium bromide is among the cationic surfactants which can be used,
- amine salts of formula N+R′R″R′″ in which the radicals R are optionally hydroxylated hydrocarbon radicals; octadecylamine hydrochloride is among the cationic surfactants which can be used,
- nonionic surfactants such as sorbitan esters, which are optionally polyoxyethylenated, in
particular polysorbate 80, polyoxyethylenated alkyl ethers; polyoxypropylated fatty alcohols such as polyoxypropylene-styrol ether; polyethylene glycol stearate, polyoxyethylenated derivatives of castor oil, polyglycerol esters, polyoxyethylenated fatty alcohols, polyoxyethylenated fatty acids, copolymers of ethylene oxide and propylene oxide, - amphoteric surfactants such as the substituted lauryl compounds of betaine;
- or a mixture of at least two of these agents.
- The solvent will be used in proportion with the concentration of the compound I and its solubility in this solvent.
- For example, compound A has a solubility of 4.3% m/V in acetyl tributyl citrate. It will be sought to have the lowest possible volume.
- The vehicle makes up the difference to 100%.
- The emollient is preferably used in a proportion of from 0.1 to 10%, in particular from 0.25 to 5%, by volume.
- The subject of the present invention is also a process for the elimination of parasites, in particularBoophilus microplus, from cattle and sheep using a direct pour-on skin solution according to the present invention, so as obtain long-lasting and broad-spectrum efficacy, the solution being applied to the animal's back, preferably along the line of the back at one or more points.
- According to a first embodiment, the process consists in applying the solution to the animals in pasture and/or before they arrive in pasture, the application preferably being repeated every month, preferably every two months.
- According to a second embodiment, the process consists in applying the solution to the animals before they arrive in the “feed Lot”, it being possible for this application to be the final one before the animals are slaughtered.
- Obviously, the process may also consist in combining these two embodiments, namely the first followed by the second.
- In all cases, the efficacy advantageously makes it possible to stop any
application 1 to 3 months before slaughter, in particular between 1.5 and 2.5 months, more particularly about two months before slaughter. - The solutions according to the invention may be applied using any means known per se, preferably using an applicator gun or a metering flask.
- The aim of the method is not therapeutic and is, in particular, to cleanse the skin and the hairs of the animals by eliminating the parasites which are present thereon, as well as their residues and dejections. The result of this is that the animals are no longer stressed by the parasites and their bites, this having positive consequences, for example on their growth and on the use of their food ration.
- Another subject of the invention is a therapeutic method using the external device according to the invention, intended for the treatment and prevention of parasitoses having pathogenic consequences.
- The subject of the present invention is also the use of the compounds I, in particular compound A, for the manufacture of a direct pour-on skin solution comprising the compound (I) in a low volume and designed to release the compound (I) onto the skin and the hairs for a contact action against the parasites of cattle and sheep, in particular cattle ticks, such asBoophilus microplus, and sheep blowfly and lice.
- The use according to the invention is directed towards producing skin solutions as described above.
- The present invention will now be described in greater detail with the aid of non-limiting embodiment examples which demonstrate the activity of the solutions according to the present invention, with reference to the attached drawings in which:
- FIG. 1 is a graph showing the efficacy, againstBoophilus microplus, of skin solutions according to the invention, with a 0.25%, 0.5% and 1% content, relative to a control, this graph including, on the x-axis, the time in days after application of the skin solutions, and, on the y-axis to the left, the number of ticks counted on the animals on which the skin solutions according to the invention are applied, and, on the y-axis to the right, the number of ticks counted in the controls;
- FIG. 2 is a graph showing the population of ticks in animals which have received the placebo according to Example 2, with, on the x-axis, the time in days, and, on the y-axis, the number of ticks; and
- FIG. 3 compares the efficacy of a skin solution according to the invention containing 1% compound A (solid circles) with a skin solution containing 1% flumethrin (rings), with, on the x-axis, the time in days, and, on the y-axis, the number of ticks.
- Preparation of the Solutions According to the Invention
Ingredient Function Amount Compound A active substance x g polyoxypropylene 15 stearyl ether emollient 5 g acetyl tributyl citrate solvent 30 g soybean oil diluent qs 100 ml - Compound A is dissolved in the solvent before being mixed with the other ingredients.
- Study of the efficacy of skin solutions according to the invention containing, respectively, 0.25, 0.50 and 1% compound A to combatBoophilus microplus.
- The study was performed on 16 young male castrated Herefords (weight ranging between 114 and 172 kg).
- Three skin solutions according to Example 1 were prepared:
- 1. 1% compound A
- 2. 0.5% compound A
- 3. 0.25% compound A
- A placebo was prepared, which differed from the skin solutions according to the invention in that it contained no compound A.
- In the studies, 1 ml of skin solution or of placebo were used per 10 kg of animal weight.
- The dose volume was applied along the line of the animal's back, from the head to the base of the tail.
- Between days −24 and −1, the animals were artificially infested on 11 occasions with 2,500Boophilus microplus larvae. The aim of 24-day infestation is to ensure that all of the stages of Boophilus microplus are present on the animal (eggs, larvae, adults).
- On
day 0, the animals receive one of the skin solutions or the placebo. - Before the skin solutions or the placebo are applied, the number of ticks present on the various animals in the different groups are counted.
- The following table indicates the values recorded, the weight of the animals and the dose of skin solution or of placebo which will be applied to each of these animals.
Number of Weight Group Animal No. ticks (in kg) Dose (ml) 1.00% 94 588 134 13.4 43 470 140 14.0 47 300 154 15.4 39 254 160 16.0 0.50% 34 706 145 14.5 99 452 143 14.3 48 375 114 11.4 45 201 153 15.3 0.25% 40 510 148 14.8 92 453 144 14.4 41 432 155 15.5 36 236 171 17.1 Placebo 96 627 150 15.0 44 482 144 14.4 93 315 140 14.0 97 292 172 17.2 - The blood-engorged female ticks which become detached are included in the count. The results are indicated in FIG. 1.
- A dose-dependent effect is obtained with 100% efficacy for the skin solution according to the invention containing 1% compound A. The less-concentrated solutions nevertheless give noteworthy results.
- The great rapidity of action of the solutions according to the invention is also noted, the 1% solution allowingBoophilus microplus to be totally eliminated in less than 2 days.
- Comparison of efficacy between a skin solution according to the invention containing 1% compound A and a skin solution containing 1% flumethrin.
- Animals of the same breed as those in Example 1 were used.
- On
day 0, the groups are treated with: - skin solution containing 1% compound A
- skin solution containing 1% flumethrin (mineral oil and ethylhexyl alcohol excipient)
- placebo (excipient identical to the solution according to the invention)
- Table 2 below indicates, for each group, the weight of the animals, the dose of skin solution received and the dose of active substance applied.
Group Animal No. Weight Dose (ml) Dose (mg/kg)−) 1% 719 141 14.1 1 Compound A 709 125 12.5 1 713 150 15.0 1 710 136 13.6 1 703 138 13.8 1 1% 706 145 14.5 1 flumethrin 711 136 13.6 1 715 132 13.2 1 702 142 14.2 1 701 127 12.7 1 Placebo 717 133 13.3 0 707 133 13.3 0 704 134 13.4 0 718 132 13.2 0 708 143 14.3 0 - From
day 2 to day 32, the animals receive 5,000 Boophilus microplus larvae three times a week. Fromday 18 to 64, the blood-engorged female ticks which become detached are collected and counted. - The results are indicated in FIGS. 2 and 3, which demonstrate the total efficacy of the skin solution according to the invention.
- Study of efficacy over time.
- Skin solutions according to the invention containing 0.25, 0.5 or 1% compound A where used in this example.
- The composition of these solutions is the same as for the above examples.
- The cattle were preinfested so as to have all of the stages ofBoophilus microplus present (infestation with 5,000 larvae, 22 days, 15 days and 8 days before application of the skin solution).
- After application of the skin solutions, the cattle are again infested with the larvae for 13 weeks, to determine the efficacy of the three concentrations.
- The results are reported in Table 3 below:
Efficacy index for each Weeks of infestation concentration after treatment 0.25% 0.5% 1.0% 1 97.6 100 100 2 98.8 100 100 3 99.7 100 100 4 99.3 100 100 5 96.7 92.9 100 6 98.6 93.2 100 7 92.4 88.6 99.7 8 85.8 83.4 100 9 28.0 37.9 79.8 10 23.0 41.4 65.3 11 18.9 55.2 61.5 12 1.7 37.3 32.2 13 8.4 48.5 46.4 - It is thus observed that noteworthy efficacy, which may last for two months or more, is obtained.
Claims (59)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/450,186 US6413542B1 (en) | 1996-03-29 | 1999-11-29 | Direct pour-on antiparasitic skin solution and methods for treating, preventing and controlling myasis |
US10/120,691 US6797724B2 (en) | 1996-03-29 | 2002-04-11 | Direct spot-on antiparasitic skin solution for domestic animals |
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9604209 | 1996-03-29 | ||
FR9604209A FR2746595B1 (en) | 1996-03-29 | 1996-03-29 | SKIN SOLUTION FOR DIRECT DEPOSIT FOR PEST CONTROL IN CATTLE AND SHEEP |
US69217896A | 1996-08-05 | 1996-08-05 | |
FR9610312 | 1996-08-20 | ||
FR9610312A FR2752525B1 (en) | 1996-08-20 | 1996-08-20 | METHOD FOR CONTROLLING MYIA OF CATTLE AND SHEEP HERBS AND COMPOSITIONS FOR CARRYING OUT SAID METHOD |
FR9703708 | 1997-03-26 | ||
FR9703708A FR2747015B1 (en) | 1996-03-29 | 1997-03-26 | SKIN SOLUTION FOR DIRECT DEPOSIT FOR PEST CONTROL IN CATTLE AND SHEEP |
US09/051,693 US6001384A (en) | 1996-08-20 | 1997-08-19 | Method for fighting against myiasis affecting cattle and sheep populations and compositions for implementing same |
US08/933,016 US6010710A (en) | 1996-03-29 | 1997-09-18 | Direct pour-on skin solution for antiparasitic use in cattle and sheep |
US09/450,186 US6413542B1 (en) | 1996-03-29 | 1999-11-29 | Direct pour-on antiparasitic skin solution and methods for treating, preventing and controlling myasis |
Related Parent Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR1997/001504 Continuation-In-Part WO1998007423A1 (en) | 1996-08-20 | 1997-08-19 | Method for fighting against myases affecting cattle and sheep populations and compositions for implementing same |
US09/051,693 Continuation-In-Part US6001384A (en) | 1996-03-29 | 1997-08-19 | Method for fighting against myiasis affecting cattle and sheep populations and compositions for implementing same |
US08/933,016 Continuation-In-Part US6010710A (en) | 1996-03-29 | 1997-09-18 | Direct pour-on skin solution for antiparasitic use in cattle and sheep |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/933,016 Continuation-In-Part US6010710A (en) | 1996-03-29 | 1997-09-18 | Direct pour-on skin solution for antiparasitic use in cattle and sheep |
US10/120,691 Division US6797724B2 (en) | 1996-03-29 | 2002-04-11 | Direct spot-on antiparasitic skin solution for domestic animals |
Publications (2)
Publication Number | Publication Date |
---|---|
US20020081327A1 true US20020081327A1 (en) | 2002-06-27 |
US6413542B1 US6413542B1 (en) | 2002-07-02 |
Family
ID=27546420
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/450,186 Expired - Lifetime US6413542B1 (en) | 1996-03-29 | 1999-11-29 | Direct pour-on antiparasitic skin solution and methods for treating, preventing and controlling myasis |
US10/120,691 Expired - Lifetime US6797724B2 (en) | 1996-03-29 | 2002-04-11 | Direct spot-on antiparasitic skin solution for domestic animals |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/120,691 Expired - Lifetime US6797724B2 (en) | 1996-03-29 | 2002-04-11 | Direct spot-on antiparasitic skin solution for domestic animals |
Country Status (1)
Country | Link |
---|---|
US (2) | US6413542B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090137524A1 (en) * | 2003-12-18 | 2009-05-28 | Denis Billen | Substituted arylpyrazoles |
US9457088B2 (en) | 2012-02-23 | 2016-10-04 | Merial, Inc. | Topical compositions comprising fipronil and permethrin and methods of use |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2739255B1 (en) * | 1995-09-29 | 1998-09-04 | Rhone Merieux | PEST CONTROL COMPOSITION FOR THE TREATMENT AND PROTECTION OF PETS |
US7262214B2 (en) | 2003-02-26 | 2007-08-28 | Merial Limited | 1-N-arylpyrazole derivatives in prevention of arthropod-borne and mosquito-borne diseases |
US6991801B2 (en) | 2003-04-04 | 2006-01-31 | Merial Limited | Topical anthelmintic veterinary formulations |
US7531186B2 (en) | 2003-12-17 | 2009-05-12 | Merial Limited | Topical formulations comprising 1-N-arylpyrazole derivatives and amitraz |
US7671034B2 (en) | 2003-12-19 | 2010-03-02 | Merial Limited | Stabilized formulation of ivermectin feed premix with an extended shelf life |
WO2006007630A1 (en) * | 2004-07-22 | 2006-01-26 | Jurox Pty Ltd | Aqueous insecticidal/parasiticide formulation |
WO2008062413A2 (en) * | 2006-11-21 | 2008-05-29 | Mitam Ltd. | Formulations of entomopathogenic fungi for insect control |
US9173728B2 (en) | 2008-11-19 | 2015-11-03 | Merial Inc. | Multi-cavity container having offset indentures for dispensing fluids |
SG171751A1 (en) | 2008-11-19 | 2011-07-28 | Merial Ltd | Compositions comprising an aryl pyrazole and/ or a formamidine methods and uses thereof |
BRPI0823302B1 (en) * | 2008-12-16 | 2017-01-31 | Virbac | liquid pharmaceutical composition containing an n-phenylpyrazole derivative, and use for the preparation of a topical veterinary drug for fighting fleas |
UA108641C2 (en) | 2010-04-02 | 2015-05-25 | PARASITICID COMPOSITION CONTAINING FOUR ACTIVE AGENTS AND METHOD OF APPLICATION | |
AU2012340351B2 (en) | 2011-11-17 | 2017-06-15 | Boehringer Ingelheim Animal Health USA Inc. | Compositions comprising an aryl pyrazole and a substituted imidazole, methods and uses thereof |
AU2015206219B2 (en) | 2014-01-20 | 2017-04-27 | Boehringer Ingelheim Animal Health USA Inc. | Topical delivery formulation |
ES2887302T3 (en) | 2014-10-31 | 2021-12-22 | Boehringer Ingelheim Animal Health Usa Inc | Parasiticidal compositions comprising fipronil |
US9943387B2 (en) | 2016-06-29 | 2018-04-17 | International Business Machines Corporation | Unmanned aerial vehicle-based system for livestock parasite amelioration |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3355736B2 (en) | 1993-12-20 | 2002-12-09 | 住友化学工業株式会社 | Insecticide, acaricide composition |
US5232940A (en) | 1985-12-20 | 1993-08-03 | Hatton Leslie R | Derivatives of N-phenylpyrazoles |
GB8713768D0 (en) | 1987-06-12 | 1987-07-15 | May & Baker Ltd | Compositions of matter |
GB8816915D0 (en) | 1988-07-15 | 1988-08-17 | May & Baker Ltd | New compositions of matter |
CA2036147A1 (en) | 1990-06-29 | 1991-12-30 | Hiroki Tomioka | A 1-pyridylimidazole derivative and its production and use |
JP3715994B2 (en) | 1993-12-21 | 2005-11-16 | 住友化学株式会社 | Pest control agent |
US5801189A (en) | 1995-04-05 | 1998-09-01 | Rhone-Poulenc Agriculture Limited | Method for combating insects |
US5885607A (en) | 1996-03-29 | 1999-03-23 | Rhone Merieux | N-phenylpyrazole-based anti-flea and anti-tick external device for cats and dogs |
FR2752525B1 (en) | 1996-08-20 | 2000-05-05 | Rhone Merieux | METHOD FOR CONTROLLING MYIA OF CATTLE AND SHEEP HERBS AND COMPOSITIONS FOR CARRYING OUT SAID METHOD |
US6010710A (en) | 1996-03-29 | 2000-01-04 | Merial | Direct pour-on skin solution for antiparasitic use in cattle and sheep |
DE19650197A1 (en) | 1996-12-04 | 1998-06-10 | Bayer Ag | 3-thiocarbamoylpyrazole derivatives |
AU6826898A (en) | 1997-03-11 | 1998-09-29 | Rhone-Poulenc Agro | Pesticidal combination |
US6256430B1 (en) * | 1998-11-23 | 2001-07-03 | Agere Systems Inc. | Optical crossconnect system comprising reconfigurable light-reflecting devices |
-
1999
- 1999-11-29 US US09/450,186 patent/US6413542B1/en not_active Expired - Lifetime
-
2002
- 2002-04-11 US US10/120,691 patent/US6797724B2/en not_active Expired - Lifetime
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090137524A1 (en) * | 2003-12-18 | 2009-05-28 | Denis Billen | Substituted arylpyrazoles |
US7960426B2 (en) | 2003-12-18 | 2011-06-14 | Pfizer Limited | Substituted arylpyrazoles |
US20110196011A1 (en) * | 2003-12-18 | 2011-08-11 | Pfizer Limited | Substituted arylpyrazoles |
US8084486B2 (en) | 2003-12-18 | 2011-12-27 | Pfizer Limited | Substituted arylpyrazoles |
US9457088B2 (en) | 2012-02-23 | 2016-10-04 | Merial, Inc. | Topical compositions comprising fipronil and permethrin and methods of use |
US9949953B2 (en) | 2012-02-23 | 2018-04-24 | Merial Inc. | Topical compositions comprising fipronil and permethrin and methods of use |
US10646473B2 (en) | 2012-02-23 | 2020-05-12 | Boehringer Ingelheim Animal Health USA Inc. | Topical compositions comprising fipronil and permethrin and methods of use |
Also Published As
Publication number | Publication date |
---|---|
US20020155147A1 (en) | 2002-10-24 |
US6413542B1 (en) | 2002-07-02 |
US6797724B2 (en) | 2004-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6010710A (en) | Direct pour-on skin solution for antiparasitic use in cattle and sheep | |
US6001384A (en) | Method for fighting against myiasis affecting cattle and sheep populations and compositions for implementing same | |
US6395765B1 (en) | Antiparasitic composition for the treatment and protection of pets | |
US6797724B2 (en) | Direct spot-on antiparasitic skin solution for domestic animals | |
KR20150085091A (en) | Local topical administration formulations containing indoxacarb | |
WO2010026370A1 (en) | A topical ectoparasiticide composition | |
AT506843B1 (en) | DIRECTLY ADAPTABLE TO THE SKIN TO REMOVE PARASITES IN BOVINE ANIMALS AND SHEEP | |
CA2578079A1 (en) | Methoprene formulations for the control of tick infestations | |
EP0915654B1 (en) | Process and composition for the antiparasitic treatment of the surroundings of animals | |
AU763484B2 (en) | Direct pour-on skin solution for antiparasitic use in cattle and sheep | |
AU2003257646B2 (en) | Direct pour-on skin solution for anitparasitic use in cattle and sheep | |
US6524603B1 (en) | Process and composition for the antiparasitic treatment of the surroundings of animals | |
MXPA97009092A (en) | Cutaneous solution for direct deposit intended for the elimination of parasites in cattle and sheep, use of a composite in such solution and treatment procedure for cattle and sheep with such solution | |
SE531435C2 (en) | Insecticide compound against fleas in mammals, especially dogs and cats | |
MXPA98003000A (en) | Method for fighting against myases affecting cattle and sheep populations and compositions for implementing same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: MERIAL, FRANCE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ETCHEGARAY, JEAN-PIERRE;JEANNIN, PHILIPPE;REEL/FRAME:010626/0930 Effective date: 20000111 |
|
AS | Assignment |
Owner name: MERIAL, FRANCE Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:ETCHEGARAY, JEAN-PIERRE;JEANNIN, PHILIPPE;REEL/FRAME:010691/0657 Effective date: 19960805 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
CC | Certificate of correction | ||
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FEPP | Fee payment procedure |
Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
FPAY | Fee payment |
Year of fee payment: 12 |